Back

Template-independent genome editing and repairing correct frameshift disease in vivo

Liu, L.; Li, K.; Zou, L.; Hou, H.; Hu, Q.; Liu, S.; Wang, S.; Wang, Y.; Li, J.; Song, C.; Chen, J.; Li, C.; Du, H.; Li, J.-L.; Chen, F.; Xu, Z.; Sun, W.; Sun, Q.; Xiong, W.

2020-11-15 neuroscience
10.1101/2020.11.13.381160 bioRxiv
Show abstract

Frameshift mutation caused by small insertions/deletions (indels) often generate truncated and non-functional proteins, which underlies 22% inherited Mendelian disorders in humans. However, there is no efficient in vivo gene therapy strategies available to date, especially in postmitotic systems. Here, we leveraged the non-homologous end joining (NHEJ) mediated non-random editing profiles to compensate the frameshift mutation in a USH1F mouse model - av3j. After treatment by the selected gRNA, about 50% editing products showed reading-frame restoration, and more than 70% targeted hair cells recovered mechanotransduction. In vivo treatment ameliorated the hearing and balance symptoms in homozygous mutant mice. Furthermore, a scale-up analysis of 114 gRNAs targeting 40 frameshift deafness mutations reveals that 65% loci have at least one gRNA with predicted therapeutic potential. Together, our study demonstrates that the NHEJ-mediated frame restoration is a simple and highly efficient therapeutic strategy for small-indel induced frameshift mutations.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.